immunoSEQ Blog

Adaptive Customers Publish Latest Results in Haematologica

Screen Shot 2014-10-23 at 2.11.16 PM

A few weeks ago, a team of researchers from University of Helsinki, University of Virginia, Cleveland Clinic, University of Turku, Adaptive Biotechnologies, and Universidad de Murcia published results from a study in which they used the immunoSEQ assay to explore the presence or lack thereof of STAT3 mutations in a certain percentage of patients with T cell… Read More→

Categorized in: Announcements |

Understanding the Placebo Effect

The placebo effect seems amazing, no side effects, no contraindications and yet surprisingly effective. If only we could understand it better. This however proves to be anything but straightforward. While conditioning has been proven to be the underlying cause for the association between mental state and physiological function, it has even been suggested that the… Read More→

Categorized in: Food for Thought |

Adaptive Biotechnologies Platform of High-Throughput Sequencing Featured in Stanford Review of Bone Marrow Transplantation

The work of Drs. Wen-Kai Weng and Everett Meyer which uses the Adaptive Biotechnologies platform of high-throughput immune receptor sequencing was highlighted in the recently published review of  the Stanford  Bone Marrow Transplantation program (bmt.stanford.edu).  The work of Drs. Weng and Meyer will also be presented at this year’s American Society of Hematology (ASH) meeting… Read More→

Categorized in: Announcements, Food for Thought |

Seattle’s Institute for Systems Biology Awarded 2 year Cancer Genomics Cloud Pilot Contract from NCI

We congratulate our colleagues at Seattle’s Institute for Systems Biology, who recently received a $6.5 million, two-year Cancer Genomics Cloud Pilots contract from the National Cancer Institute (or NCI, a division of the National Institutes of Health), in collaboration with Google and SRA International. Other awardees include The Broad Institute and Seven Bridges Genomics. Last year, NCI… Read More→

Categorized in: Food for Thought, News |

The Microbial Olympics

Untitled

This blog post is written in light of discomforting news about Ebola infections in Spain and case emergence in the US, as well as the breaking news of 628 respiratory enterovirus EV-D68 infections in 44 U.S. states, which in some patients caused severe respiratory illness and even polio-like symptoms. It appears to be an opportune… Read More→

Categorized in: Food for Thought |

Looking for inactive genes offers new angle for oncology treatments

Oncology has generally trended from generic treatments to more specific treatments.  For the most part, this has trended toward seeking the genetic anomalies within the cancer cells and targeting those mutations for specific treatment.  Generic treatments have dramatic and unavoidable side-affects, but specific treatments tend to be prone to drug resistance.  Researchers recently published in the August 28th issue… Read More→

Categorized in: Food for Thought |

New studies providing insights on the adaptive immune response

The adaptive immune response is believed to be shaped by signaling from the innate arm of the immune system. Three articles published on the September 25th issue of Science by the European BLUEPRINT initiative provide new insights into the latter. The first two studies use genome-wide epigenetic and transcription analyses to understand the phenomenon of… Read More→

Categorized in: Food for Thought |